Skip to content
Treating EGFR Patients After Tarceva Stops Working episode artwork

May 19, 2014 2 min

Treating EGFR Patients After Tarceva Stops Working

from GRACEcast Lung Cancer Video Hosted by cancerGRACE - H. Jack West, MD

Tarceva (erlotinib) has greatly helped EGFR positive lung cancer patients, but eventually it stops working. Dr. Jonathan Goldman of UCLA Jonsson Comprehensive Cancer Center talks about the next generation EGFR inhibitors that may soon become available. February 2014.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Treating EGFR Patients After Tarceva Stops Working

0:00 2:47

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of GRACEcast Lung Cancer Video?

This episode is 2 minutes long.

When was this GRACEcast Lung Cancer Video episode published?

This episode was published on May 19, 2014.

Can I download this GRACEcast Lung Cancer Video episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.